Business » UNN

How Healthcare Affects the Economy (and Vice Versa)

2Feb

By UNN News DeskNo Comments

Business

How Healthcare Affects the Economy (and Vice Versa)

Healthcare. Economy. Two seemingly separate worlds, right? Wrong! They're more entangled than a stethoscope cord, each influencing the other in a complex tango of health and wealth. So, let's peek behind the curtain and explore the fascinating dance between healthcare and the economic stage. The Healthy Worker, the Prosperous Nation: Think of a workforce as a machine. When its gears are well-oiled and healthy, it hums with productivity, driving economic growth. But when illness strikes, the gears grind, output stalls, and the whole system sputters. This is precisely why healthy citizens translate to a thriving economy. Reduced Absenteeism: A workforce battling illness spends more time at home and less at work, leading to decreased productivity and financial losses for both em...

2Feb

By UNN News DeskNo Comments

News & Events, Business

Your Guide to the Zacks Industry Rank

Investing can feel like navigating a jungle gym of confusing metrics and dizzying charts. But amidst the financial foliage, the Zacks Industry Rank stands out as a beacon of clarity. It's like a personalized tour guide, whispering sweet nothings (or harsh realities) about the industries you're considering. But how does this ranking work, and what whispers should you listen to? Let's delve into the fascinating world of Zacks Industry Ranks! The Nuts and Bolts: Zacks Industry Rank The Zacks Industry Rank is a simple, straightforward number assigned to each of the 265 industry groups tracked by Zacks. These numbers range from 1 (the best!) to 265 (the... not-so-good). But how do these ranks magically appear? Buckle up, because here comes the fun part: The Average Zacks Rank: Imagi...

Why Gilead Sciences Stock Nosedived on Monday

2Feb

By UNN News DeskNo Comments

News & Events, Business

Why Gilead Sciences Stock Nosedived on Monday

NASDAQ: Gilead Sciences (GILD), a sturdy in the drug area, encountered a difficult day in the stock trade this Monday. Financial backers answered disheartening clinical preliminary outcomes for one of its investigational drugs by driving the organization's portion cost somewhere around more than 10%, even as the more extensive S&P 500 list shut emphatically, acquiring almost 0.3%. Gilead Sciences Stock down on Monday Image credits: https://www.tradingview.com/ The difficulty happened in a late-stage preliminary for Trodelvy, a supported malignant growth drug. Gilead wanted to include patients with advanced or metastatic non-small cell lung cancer (NSCLC) who had progressed after platinum-based chemotherapy and checkpoint inhibitor therapy in the scope of its FDA approval. Sad...

The J.P. Morgan Healthcare Conference: A Who’s Who of Industry Titans Shaping the Future

2Feb

By Richard TurnerNo Comments

News & Events, Business

The J.P. Morgan Healthcare Conference: A Who’s Who of Industry Titans Shaping the Future

42nd J.P. Morgan Healthcare Conference 2024 Mark your calendars, healthcare innovators! The J.P. Morgan Healthcare Conference, the undisputed Davos of the healthcare world, is back and bigger than ever. From January 8th to 11th, 2024, San Francisco will become a buzzing hive mind of leading executives, investors, and thought leaders, all eager to dissect the future of healthcare. But with such a star-studded line-up, where do you even begin? Worry not, curious souls, for this blog will serve as your ultimate guide to the conference's most distinguished panelists. Leading the charge are the keynote speakers: Jamie Dimon, Chairman and CEO of JPMorgan Chase: This financial titan and industry veteran will undoubtedly offer his unique perspective on the intersection of healthcare and...

Why Healthcare Bankruptcies are Spiraling Out of Control?

2Feb

By Richard TurnerNo Comments

News & Events, Business

Why Healthcare Bankruptcies are Spiraling Out of Control?

The American Dream on Life Support: Why Healthcare Bankruptcies are Spiraling Out of Control In the land of opportunity, a silent tragedy is unfolding. Millions of Americans are drowning in a sea of medical debt, their hopes for a healthy future dashed against the jagged rocks of soaring healthcare costs. This isn't a fictional tale of dystopia; it's the harsh reality for countless families struggling to navigate the labyrinthine American healthcare system. And the consequences are dire: bankruptcies fueled by medical bills are on the rise, leaving a trail of financial devastation and shattered dreams. A recent article in the Financial Times (https://www.ft.com/content/65dfbc81-2641-48fa-a40a-647076943194: https://www.ft.com/content/65dfbc81-2641-48fa-a40a-647076943194) paints a stark ...